Coronary Artery Disease Management

Comprehensive Treatment Approach

The European Society of Cardiology recommends improvement of lifestyle factors alongside pharmacological management for coronary artery disease (CAD) patients 1
Exercise-based cardiac rehabilitation significantly reduces cardiovascular mortality and morbidity while improving risk factor control in CAD patients 1
Annual influenza vaccination is recommended for CAD patients, especially in elderly patients, to reduce mortality risk 1

Beta-blockers and/or calcium channel blockers (CCBs) are recommended as initial treatment to control heart rate and angina symptoms in CAD patients 1, 2, 4
Short-acting nitrates should be prescribed for immediate relief of effort angina in CAD patients 3, 4
Calcium channel blockers are an appropriate alternative when beta-blockers are contraindicated or poorly tolerated in CAD patients 4

Aspirin 75-100 mg daily is recommended in CAD patients with previous myocardial infarction or revascularization for event prevention 5
Statins are recommended for all CAD patients to reduce the risk of major vascular events 6
Consider adding ezetimibe if LDL targets are not achieved with maximum tolerated statin dose in CAD patients 3

Evaluate symptom severity, risk factors, and comorbidities in CAD patients to guide treatment decisions 7
Assess for contraindications to specific medications in CAD patients before initiating therapy 4
Start lifestyle modifications, short-acting nitrates, aspirin, and statin therapy in CAD patients as initial treatment 1, 3, 5, 6

Patient education about the disease, risk factors, and treatment strategy is crucial for long-term success in CAD management 1
Avoid combining ivabradine with non-dihydropyridine CCBs in CAD patients due to potential drug interactions 4
Nitrates should not be used in patients with hypertrophic obstructive cardiomyopathy or in combination with phosphodiesterase inhibitors 3
Involvement of cardiologists, primary care physicians, nurses, dieticians, physiotherapists, and other healthcare professionals improves outcomes in CAD patients 1
Medical therapy should be optimized before considering revascularization, except in high-risk CAD patients with significant symptoms despite medical therapy 2